Andrx, Schering Settle Claritin-D Patent Dispute

Law360, New York (October 24, 2003, 12:00 AM EDT) -- Andrx Corp. settled a patent dispute with Schering-Plough Corp. over Andrx's generic version of the Claritin-D 24-hour allergy medicine, the companies said Friday.

Andrx will receive a license to a patent for the drug from Schering-Plough, the company said. Andrx said that the lawsuit would be dismissed, but did not disclose financial terms of the settlement.

Andrx's generic Claritin-D 24 is marketed by Perrigo Company as an over-the-counter product used for the relief of symptoms of seasonal allergic rhinitis, commonly known as hay fever, the company...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.